Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2010127177) PYRIDO [4,3-B] INDOLES AND METHODS OF USE
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2010/127177 International Application No.: PCT/US2010/033053
Publication Date: 04.11.2010 International Filing Date: 29.04.2010
IPC:
A01N 43/42 (2006.01)
A HUMAN NECESSITIES
01
AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
N
PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
43
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
34
having rings with one nitrogen atom as the only ring hetero atom
40
six-membered rings
42
condensed with carbocyclic rings
Applicants:
MEDIVATION TECHNOLOGIES, INC. [US/US]; 201 Spear Street, 3rd Floor San Francisco, CA 94105, US (AllExceptUS)
JAIN, Rajendra, Parasmal [IN/IN]; IN (UsOnly)
CHAKRAVARTY, Sarvajit [US/US]; US (UsOnly)
Inventors:
JAIN, Rajendra, Parasmal; IN
CHAKRAVARTY, Sarvajit; US
Agent:
REANEY, Shannon; Morrison & Foerster LLP 755 Page Mill Road Palo Alto, CA 94304-1018, US
Priority Data:
1136/MUM/200929.04.2009IN
61/181,26226.05.2009US
Title (EN) PYRIDO [4,3-B] INDOLES AND METHODS OF USE
(FR) PYRIDO[4,3-B]INDOLES ET PROCÉDÉS D'UTILISATION
Abstract:
(EN) New heterocyclic compounds that may be used to modulate a histamine receptor in an individual are described. Pyrido[4,3-b]indoles are described, as are pharmaceutical compositions comprising the compounds and methods of using the compounds in a variety of therapeutic applications, including the treatment of a cognitive disorder, psychotic disorder, neurotransmitter-mediated disorder and/or a neuronal disorder.
(FR) L'invention porte sur de nouveaux composés hétérocycliques qui peuvent être utilisés pour moduler un récepteur de l'histamine chez un individu. Des pyrido[4,3-B]indoles sont décrits, ainsi que des compositions pharmaceutiques comprenant les composés et des procédés d'utilisation des composés dans une variété d'applications thérapeutiques, comprenant le traitement d'un trouble cognitif, d'un trouble psychotique, d'un trouble à médiation par neurotransmetteur et/ou d'un trouble neuronal.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
EP2424364US20120136008JP2012525430CN102480955CA2760541AU2010242910
IN8376/CHENP/2011BRPI1006602